Development
Medtronic plc
MDT
$87.44
$0.440.51%
NYSE
| 01/26/2024 | 10/27/2023 | 07/28/2023 | 04/28/2023 | 01/27/2023 | |
|---|---|---|---|---|---|
| Net Income | 45.43% | 14.92% | -32.91% | -3.60% | 186.42% |
| Total Depreciation and Amortization | -3.42% | 0.00% | 2.28% | -3.24% | 1.19% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -104.00% | -25.53% | 225.67% | -227.21% | 17.60% |
| Change in Net Operating Assets | 146.58% | -33.05% | -247.49% | 217.47% | -57.81% |
| Cash from Operations | 274.28% | -24.46% | -64.43% | 56.29% | 70.72% |
| Capital Expenditure | 24.95% | -30.23% | 6.35% | -13.86% | -2.79% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -136.36% | -- | -- | -- | 100.00% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -623.73% | 131.89% | -90.72% | -315.56% | 130.61% |
| Cash from Investing | -66.75% | 21.34% | -13.47% | -65.51% | 74.96% |
| Total Debt Issued | -137.88% | 64.20% | -63.07% | 390.58% | -92.70% |
| Total Debt Repaid | -- | -- | -- | -574.61% | -- |
| Issuance of Common Stock | -20.83% | -6.49% | -22.22% | 76.79% | -49.09% |
| Repurchase of Common Stock | 41.59% | -48.68% | -56.70% | -36.62% | 49.65% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 0.11% | 0.00% | -1.44% | -0.11% | 0.00% |
| Other Financing Activities | -222.36% | 2,112.50% | 93.98% | 81.50% | -522.94% |
| Cash from Financing | -1,566.67% | 82.04% | 89.75% | -129.15% | -170.80% |
| Foreign Exchange rate Adjustments | 125.14% | -348.72% | 47.30% | -113.70% | 634.65% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | 200.00% |
| Net Change in Cash | 1,214.29% | 86.27% | 93.15% | -873.53% | -111.38% |